Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07548853 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Clinical Study of TS-172 in Hyperphosphatemia Patients on Peritoneal Dialysis

StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Start date changed from estimate of Apr 2026 to May 13, 2026v3
  2. Recruitment opened
    • Study sites: 0 to 1
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
An open-label, single-arm clinical study of TS-172 in hyperphosphatemia patients on peritoneal dialysis
Trial Details
NCT Number NCT07548853
Lead Sponsor Taisho Pharmaceutical Co., Ltd.
Conditions
(from sponsor)		 Hyperphosphatemia Patients on Peritoneal Dialysis
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov